Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 4/20 | 0.73 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.73 |
| ▸ | PGR | P06401 | 3/20 | 0.73 |
| ▸ | MMP2 | P08253 | 12/20 | 0.67 |
| ▸ | MMP9 | P14780 | 12/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3123148 | 1.00 | NR3C2 (0.73) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL3134951 | 1.00 | NR3C2 (0.73) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL3123139 | 1.00 | NR3C2 (0.73) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL3131411 | 0.90 | NR3C1 (0.70) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL3131457 | 0.90 | NR3C1 (0.70) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL3131420 | 0.90 | NR3C1 (0.70) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL7301426 | 0.86 | MMP9 (0.62) | NR3C2NR3C1PGRMMP2MMP9 | |
| SCHEMBL3154749 | 0.85 | MMP9 (0.88) | NR3C1MMP2MMP9KMT2AMEN1 | |
| SCHEMBL3124795 | 0.85 | NR3C1 (0.76) | NR3C2NR3C1PGR | |
| SCHEMBL3154764 | 0.85 | MMP9 (0.88) | NR3C1MMP2MMP9KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11471868-B2 | Redox dehydration coupling catalysts and methods related thereto | EMORY UNIVERSITY (US) | 2022-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11471868-B2 | Redox dehydration coupling catalysts and methods related thereto | SCLY, TST, SQOR | NR3C2 1162/4885NR3C1 2928/4885PGR 4122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.